Healthcare | July 23, 2025
Fortis and Gleneagles India deepen collaboration to drive growth
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
Subscribe To Our Newsletter & Stay Updated
